Synopsys, Inc. $SNPS Shares Acquired by Czech National Bank

Czech National Bank lifted its position in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 4.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 54,526 shares of the semiconductor company’s stock after buying an additional 2,421 shares during the quarter. Czech National Bank’s holdings in Synopsys were worth $24,322,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Sankala Group LLC acquired a new stake in shares of Synopsys during the fourth quarter worth about $25,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys in the fourth quarter valued at approximately $28,000. IMG Wealth Management Inc. acquired a new position in shares of Synopsys in the first quarter valued at approximately $30,000. Atlas Capital Advisors Inc. acquired a new position in shares of Synopsys in the fourth quarter valued at approximately $32,000. Finally, Geneos Wealth Management Inc. increased its stake in Synopsys by 151.5% during the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock worth $33,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Trading Up 2.5%

NASDAQ:SNPS opened at $415.99 on Friday. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $628.89. The stock has a market cap of $79.65 billion, a P/E ratio of 96.29, a P/E/G ratio of 2.38 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The stock has a 50-day simple moving average of $433.42 and a 200-day simple moving average of $446.79.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter last year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Insider Buying and Selling at Synopsys

In other news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on SNPS shares. Stifel Nicolaus increased their target price on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Bank of America boosted their price target on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. BNP Paribas Exane increased their price objective on Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. Finally, Citigroup lifted their target price on Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $570.06.

Get Our Latest Report on SNPS

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.